{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:56:01Z","timestamp":1776142561158,"version":"3.50.1"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Breast cancer with gastric metastasis is extremely rare. Non-persistence with adjuvant endocrine therapy is associated with increased recurrence\/metastasis risk in hormone receptor-positive (HR+) breast cancer. A 33-year-old female was initially diagnosed with left breast cancer in July 2011, undergoing modified radical mastectomy, adjuvant chemotherapy, radiotherapy, and endocrine therapy (discontinued voluntarily after 1 year). In February 2025, she presented with low back pain and epigastric discomfort; examinations confirmed gastric and multiple bone metastases (ER+,PR+,HER2-). She received first-line endocrine therapy (letrozole+ribociclib+goserelin) combined with denosumab. Re-examination in September 2025 showed normal CEA, significantly decreased CA153, and no disease progression per RECIST 1.1. This case suggests that early endocrine therapy discontinuation may potentially contribute to late recurrence\/metastasis. Breast cancer gastric metastasis diagnosis relies on medical history, gastroscopy, and immunohistochemistry (GATA3+, CK7+, CK20-). The combination regimen yielded favorable efficacy, providing clinical reference for similar rare cases.<\/jats:p>","DOI":"10.3389\/fonc.2026.1773152","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:21:50Z","timestamp":1776140510000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Rare gastric and bone metastases after early endocrine therapy discontinuation in hormone receptor-positive breast cancer: lessons and therapeutic insights"],"prefix":"10.3389","volume":"16","author":[{"given":"Minjun","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Dongyang People\u2019s Hospital Affiliated to Wenzhou Medical University","place":["Dongyang, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guinv","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Dongyang People\u2019s Hospital Affiliated to Wenzhou Medical University","place":["Dongyang, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinyan","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Dongyang People\u2019s Hospital Affiliated to Wenzhou Medical University","place":["Dongyang, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca: A Cancer J For Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10549-022-06849-0","article-title":"Preventing metastatic recurrence in low-risk er\/pr\u2009+\u2009breast cancer patients\u2014a retrospective clinical study exploring the evolving challenge of persistence with adjuvant endocrine therapy","volume":"198","author":"Kuhn","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1001\/jamaoncol.2025.3700","article-title":"Ribociclib plus endocrine therapy in hormone receptor\u2013positive\/erbb2 -negative early breast cancer","volume":"11","author":"Fasching","year":"2025","journal-title":"JAMA Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1430881","article-title":"Case report: gastric metastasis of breast cancer","volume":"14","author":"Zhao","year":"2024","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1573163","article-title":"Breast cancer metastases to the stomach with endoscopic submucosal dissection: a case report and literature study","volume":"15","author":"Zhao","year":"2025","journal-title":"Front Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6703","article-title":"Metastatic gastric cancer from breast carcinoma: a report of 78 cases","volume":"14","author":"Xu","year":"2017","journal-title":"Oncol Lett"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","volume":"378","author":"Davies","year":"2011","journal-title":"Lancet (British Edition)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1039320","article-title":"Extended adjuvant endocrine therapy for women with hormone receptor-positive early breast cancer: a meta-analysis with trial sequential analysis of randomized controlled trials","volume":"12","author":"Xie","year":"2022","journal-title":"Front Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15164190","article-title":"Extended adjuvant endocrine therapy in early breast cancer patients\u2014review and perspectives","volume":"15","author":"Bekes","year":"2023","journal-title":"Cancers"},{"key":"B11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ","article-title":"Immunohistochemical evaluation of gata3 expression in tumors and normal tissues","volume":"138","author":"Liu","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.humpath.2015.09.015","article-title":"Gata-3 and foxa1 expression is useful to differentiate breast carcinoma from other carcinomas","volume":"47","author":"Davis","year":"2016","journal-title":"Hum Pathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022527","article-title":"Widespread metastasis to the stomach 10 years after primary breast cancer: a case report and review of the literature","volume":"99","author":"Fu","year":"2020","journal-title":"Med (Baltimore)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.09.019","article-title":"Esmo clinical practice guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer","volume":"32","author":"Gennari","year":"2021","journal-title":"Ann Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s44178-022-00007-8","article-title":"Caca guidelines for holistic integrative management of breast cancer","volume":"1","author":"Wu","year":"2022","journal-title":"Holistic Integr Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.07.019","article-title":"Bone health in cancer: esmo clinical practice guidelines","volume":"31","author":"Coleman","year":"2020","journal-title":"Ann Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1773152\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:21:57Z","timestamp":1776140517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1773152\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":16,"alternative-id":["10.3389\/fonc.2026.1773152"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1773152","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"article-number":"1773152"}}